SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027361
Filing Date
2023-08-09
Accepted
2023-08-09 16:26:44
Documents
96
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1361227
2 ex10-1.htm EX-10.1 1523331
3 ex31-1.htm EX-31.1 17175
4 ex31-2.htm EX-31.2 11458
5 ex32-1.htm EX-32.1 4935
  Complete submission text file 0001493152-23-027361.txt   10167662

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hrow-20230630.xsd EX-101.SCH 70586
7 XBRL CALCULATION FILE hrow-20230630_cal.xml EX-101.CAL 86412
8 XBRL DEFINITION FILE hrow-20230630_def.xml EX-101.DEF 345736
9 XBRL LABEL FILE hrow-20230630_lab.xml EX-101.LAB 528613
10 XBRL PRESENTATION FILE hrow-20230630_pre.xml EX-101.PRE 445733
90 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1370042
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 231155601
SIC: 2834 Pharmaceutical Preparations